staff_photo

 

The following lists the professional staff, organized by role. It includes management, scientific advisors, and fellows. Biographies are available by clicking on the links or scrolling down the page.

 

iValue Team

 

Role Name Background Fields
Founder Christopher Gardner Partner, PricewaterhouseCoopers LLP
• Engineering/Communications
• Physics
• Software
Distinguished Thought Leader Pierre Everaert

Governor, World Economic Forum; Chairman Philips NA

• Medical Devices
• Medical Diagnostics
Managing Director of Research and Physical Sciences Khasha Mohammadi Member of the Technical Staff, Bell Labs
• Engineering/Communications
• Medical Devices
Managing Director of Business Development Michele Sprietsma

Energy Consulting, ITEC Capital Markets and Director of Marketing and Business Strategy, Lucent

• Energy/Exchange
• Engineering/Communications
Scientific Advisor Jie Wu Pan

R&D Scientist, Independent Forensics

• Biomedicine
• Chemistry and Materials
• Therapeutics/Vaccines
Scientific Advisor Jeff Carbeck

Chief Technology Officer, Arsenal Medical

• Chemistry and Materials
• Medical Devices
• Micro/Nanotechnology
Scientific Advisor Yigal Komem

Professor of Materials Engineering, Technion

• Materials Science/Engineering
• Microelectronics and Sensors
• Nanotechnology
Scientific Advisor Emanuele Ostuni

VP Business Development, Nano Terra

• Chemistry and Materials
• Micro/Nanotechnology
• Therapeutics/Vaccines
Business Advisor Rainer Famulla

Advisor, Private Equity

• Information Technology
• Finance
Business Advisor Albert Pan

NIH Post-doc, U of Chicago

• Biomedicine
• Chemistry and Materials
• Therapeutics/Vaccines
Business Advisor Derek Reisfield

Founder, i-hatch Ventures

• Internet
• Finance
Business Advisor Chen-Li Sung Surgeon, Tripler Army Medical Center; Venture Capitalist, Paramount Venture Capital
• Biomedicine
• Disease Areas
• Therapeutics/Vaccines
Business Advisor Ray Trotta Chairman of the Advisory Board and a member of the faculty of the Walter E. Heller College of Business Administration at Roosevelt University
• Professional Development
• Finance

Management

ChrisChristopherGardner is the founder of iValue. He is the author of Measuring Value in Healthcare (2008) highlighted as among the best papers on the science website arXiv.com, and the highly acclaimed book The Valuation of Information Technology: A Guide for Strategy Development, Valuation, and Financial Planning (John Wiley & Sons, 2000). Previously he was a partner at PricewaterhouseCoopers LLP from 1999-2002 where he led the Information Technology Strategy Group in the New York office. He was a vice president at Bain & Company from 1996-1997 and worked at A.T. Kearney from 1992-1995, where he was elected principal by the Board of Directors. He began his career as a management consultant at McKinsey & Company as a specialist from 1989-1992. He has served clients across a wide-range of major industries. Prior to consulting, he worked in the high technology industry for over 8 years. He joined the Digital Equipment Corporation after graduation, and worked as a manager in the semiconductor, office workstation, and VAX computer system development groups, from 1980 to 1988. With the support of Digital he co-founded The Software Agency in 1984, a company engaged in the business of representing software authors to software publishers. He was educated at the University of Chicago where he received his MBA in Finance in 1980 and a BS in Physics a year earlier in 1979. He spent his summers working at Fermilab and at the Enrico Fermi Institute and is a graduate of the Bronx High School of Science. He can be reached at cgardner@i-value.com.

 

PierrePierre Jean Everaert is a distinguished thought leader at iValue and a former Governor of the World Economic Forum. He is a Senior Advisor for Clearwater Capital Partners and former Chairman of the Board of InBev NV/SA. He served as Chairman of Baan beginning in 1998 and later as Chairman and interim CEO until its divestiture in 2001. He is the president of E.C. Consulting BV founded in 1996 and Baltic Investment BV founded in 1997. Pierre was Vice Chairman of the Board of Management of Philips Electronics NV in Eindhoven and Chairman of the North American Philips Corporation starting 1992. From 1985 to 1992, he was President and CEO of Koninklijke Ahold NV. He was a Membre du Directoire of Générale Biscuit in 1979 and CEO of General Biscuits of America. Prior to that he served Goodyear International Corporation for fifteen years with his final position in 1978 being Managing Director of Gummiwerke Fulda. At various periods he was a board member of Eurosia, Paribas NV, Scott Paper, Burry Inc., Ezaki-Glico, and several European manufacturers and government associations. A US citizen, born in Belgium, he graduated in industrial engineering from the University of Louvain, Belgium in 1963 and received a Masters Degree in business administration. In 1994 he was awarded an honorary Doctors of Law degree from the University of Rochester. He was named professor at the Universities Gent-Leuven Vlerick School of Business in the fall of 1997. He is a guest lecturer at the Harvard Business School, the University of Michigan, and Cornell University. He co-authored with Prof. C.K. Prahalad and Prof. Rosabeth Moss Kanter the “The Organization of the Future” under the signature of Prof. Peter Drucker, published in January 1997. He can be reached at peveraert@i-value.com.

 

Pierre

Michele Sprietsma is managing director of business development at i-Value. Prior to joining i-Value, Michele was President and founder of ITEC Capital Markets – a boutique consulting company formed to develop innovative products for the energy futures market and customized software for the financial industry. Michele is career veteran of the high tech industry with over 15 years of experience in dealing with real time software systems designed specifically for the telecommunications industry. In the telecom field, Michele held numerous positions in engineering, project management, and business development. Her responsibilities included managing North American, European, and Asia Pacific customer accounts. Michele received her B.S. & M.S. degrees in Industrial Engineering and Operations Research from Virginia Tech, and graduate studies in Electrical Engineering from SMU. She is a member of Tau Beta Pi Academic Honorary Society. Michele received NCAA All American status as a Division I swimmer, held numerous local, state, and national records. She can be reached at msprietsma@i-value.com.

 

Pierre

Khasha Mohammadi is managing director of research and physical sciences at iValue. He has significant experience advising clients in patent evaluation and technology licensing. He has evaluated more than 1000 patents and received three patents himself related to telecommunication architecture for cable and telephony networks.  Khasha also contributed to the development of key technologies such as 56K modems and multimedia messaging. At AT&T Bell Laboratories , he helped develop the telecommunication industry standards and technologies for ATM (Asynchronous Transfer Mode) as well as  business and technical aspects of Digital Subscriber Lines (DSL) and transition of the cable industry to a digital environment in support of video and telecommunication services. His past and current clients include: AT&T, Bellsouth, Cisco Systems, Lucent Technologies, Samsung, Sony and State Farm Insurance. He has authored several papers on telecommunication network architecture and technology.  He is an adjunct professor in the Telecommunication Management Department at Stevens Institute of Technology.  He holds Masters and Ph.D. degrees in Electrical Engineering from the University of Minnesota. He can be reached at kmohammadi@i-value.com.

 

 

Scientific Advisors

 

Pierre

Jie Wu Pan is a scientific advisor for iValue. She is a specialist in electron paramagnetic resonance, membrane proteins, ion channels, biochemistry, molecular biology, and forensics biology. She is an experienced management consultant, and was a key member of a team that developed a Web 2.0 strategy for a large professional services firm. She has performed molecular biological and biochemical experiments to study protein structures, collected functional and structural information on the proteins by borrowing techniques from physics and biology, and quantitatively analyzed experimental data and built molecular models through computer simulation. As a project leader, she directed and collaborated with other laboratories worldwide to solve a long-standing problem in protein structure Jie has a Ph.D. in Biophysics from the University of Virginia and a B.S. in Biological Sciences from the University of Science and Technology of China (USTC). She can be reached at jwupan@i-value.com.

 

PierreJeff Carbeck is a scientific advisor for iValue specializing in healthcare, cleantech, and nanotechnology. He is co-founder and Chief Technology Officer of Arsenal Medical (Formerly WMR Biomedical) as well as a Clean Energy Fellow at New England Clean Energy Council. Previously he was a faculty member of the departments of Chemical Engineering and Molecular Biology at Princeton University. At Princeton he built a research program focused on biochemical engineering, material science, and nanotechnology. He also served as the Director of the Program in Engineering Biology. He spent two years doing post doctorate research at Harvard University in the Department of Chemistry and Chemical Biology. Jeff earned his PhD in Materials Science from MIT in 1996 and received a BSE in Material Science from the University of Michigan in 1990

 

Pierre

Yigal Komem is a scientific advisor for iValue specializing in materials science, engineering, and related technologies. He is a Professor Emeritus of Materials Engineering at Technion - Israel Institute of Technology. He is an expert in thin metal, semiconductor, and oxide films for microelectronic and sensing devices. He held administrative positions at the Technion, and faculty and research positions in universities and industrial laboratories in the US, France, Australia, and Japan. He has consulted to Israeli and US companies, chaired national and international committees and been associate editor for scientific journals. He has participated in many international conferences, contributed papers, invited lectures and sessions chair, and published over 160 papers. He holds a D. Sc., Materials Engineering, M. Sc., Materials Engineering and B. Sc. Mechanical Engineering, Technion - Israel Institute of Technology

 

PierreEmanuele Ostuni is a scientific  advisor for iValue specializing in nanotechnology. He is currently Vice President of Business Development: at Nano Terra Inc., Emanuele oversees the identification of target sectors and partners along with the process by which collaboration programs and value sharing arrangements are defined.  He has been personally involved in closing the majority of the 2008 deals and all of the deals currently in progress.  Prior to Nano Terra, he was a Manager at McKinsey & Co. in the Boston and Philadelphia offices where he worked with healthcare and high-tech clients on issues of strategy, growth, licensing and M&A.  Before McKinsey he was a Senior Research Investigator at Surface Logix, a company founded by George Whitesides and Carmichael Roberts.  There he helped to establish the company and developed the Pharmacomer platform for discovering new drugs.  Emanuele was a Glaxo Wellcome fellow at Harvard University where he completed his PhD in Physical Chemistry under the supervision of George Whitesides.  He was the recipient of an NSF summer fellowship at NIST to study small angle neutron scattering, and holds BS (cum laude) and MS (distinction) degrees in chemistry from Georgetown University.  Emanuele has co-authored over 30 publications and is co-inventor on over 30 patents

 

Business Advisors

PierreRainer Famulla is a strategy advisor for iValue. He pursues interests in private equity investments and capital management. Previously a consultant, he held senior positions at Accenture, Bain & Company, A.T. Kearney, and McKinsey & Company. Early in his carreer, he taught Economics and worked for the United Nations in Latin America and the Carribbean. He holds a PhD in Economics from University of Karlsruhe, and enjoyed a postgraduate fellowship to the University of Beijing.

 

Pierre

Albert Pan is a computational biology advisor for iValue specializing in chemistry and biochemistry. He is an NIH postdoctoral fellow in the Department of Biochemistry and Molecular Biology at the University of Chicago. His research interests include biophysics, biofuels, computational methodology development, potassium ion channel gating, bacterial signal transduction, G-protein coupled receptors, swarming models, and supercooled liquids. He holds a Ph.D. in chemistry from the University of California at Berkeley, advisor David Chandler, and a BA in chemistry and physics from Harvard University, Magna Cum Laude

 

PierreDerek Reisfield is an investment advisor for iValue as well as an international strategy consultant and private investor who specializes in Internet, Media, Technology and Consumer Products. Currently Derek serves as the Vice Chairman of Fliptrack, Inc.  Mr. Reisfield is the co-founder of several firms, including Marketwatch which was sold for $500million to Dow Jones, Luminant a $100m interactive services company, and i-hatch Ventures a $140m+ investment fund. He was also instrumental in the development of several successful firms, including MediaStrands, Every Baby Company, Provell, and Sportsline. Derek served as the founding President of the New Media Division of CBS, and he was Vice President of Business Development at the CBS Corporation and its predecessor, The Westinghouse Electric Corporation. Mr. Reisfield was also the Co-Founder of the Media and Telecom practice of Mitchell Madison and a leader of McKinsey & Company’s Media practice. Derek Reisfield graduated from Wesleyan University, where he won the Davenport Prize, and he received his A.M. from the Annenberg School of Communications at USC

 
RayChen-Li Sung, M.D. is a clinical healthcare advisor for iValue. Dr. Sung received his M.D. from The Mt. Sinai School of Medicine and received residency training in general surgery at St. Barnabas Hospital in New Jersey and the Tripler Army Medical Center in Hawaii. He worked as a venture capitalist with Paramount Capital Investments in biotechnology, and as a biotechnology equity research analyst at USBancorp Piper Jaffray. He has identified promising pharmaceutical candidates, led due diligence regarding scientific validity and commercial viability, negotiated licensing terms, and successfully in-licensed two late-stage compounds with potential markets in excess of $1 billion. He has also written business plans for pharmaceutical start-ups and for acquired public entities, resulting in a public merger and a successful restructuring. He received his undergraduate degree from Williams College and is fluent on German and Mandarin
 
RayRay Trotta is a cofounder of iValue a technology valuation firm. He has a unique blend of consulting, academic, and financial services experience. He is the author of "Translating Strategy into Shareholder Value: A Company Wide Approach to Value Creation" (AMACOM 2003) which introduces the Step-Wise Approach to Value (SWAV), a process that provides both financial and other tools for evaluating strategic alternatives. It has received accolades from executives at Sears, McDonalds, and the American Heart Association. He has taught and written courses on technology valuation nationally. Mr. Trotta speaks frequently on technology and finance topics. He focuses on creating innovative strategy and operations solutions for his client base. Before launching iValue, he was a member of the Financial Services Consulting Practice of KPMG Peat Marwick. His clients include Fortune 200 industrial manufacturers, money center banks, and multinational corporations such as CitiGroup and Siemens Corporation. Mr. Trotta's specialties include technology strategy, merger integration, startup advisory, business process reengineering, activity-based management, and systems assessment. Mr. Trotta has twenty years of business experience that includes commercial lending, real estate syndication financing, equipment leasing, and portfolio acquisition.Mr. Trotta is the Chairman of the Advisory Board to the business school and a member of the graduate school faculty of the Walter E. Heller College of Business Administration at Roosevelt University. He can be reached at rtrotta@i-value.com.